Depression is one of the most common mental disorders. Despite the numerous medications, there are still the limitations such as side effects and treatment-resistance in depression treating. Herbal medicine has been considered as supplemental and alternative therapy for psychiatric disorders. Psycodigest is an antidepressant Persian formula composed of Aloysia triphylla, Citrus aurantium, Echium amoneum, Lavandula angustifolia, Melissa officinalis, Salix aegyptiaca, Valeriana officinalis, Viola odorata, and Cinnamomum zeylanicum. This survey was performed to evaluate the effect of the chronic administration of Psycodigest in chronic unpredictable mild stress (CUMS) mice behavior and its safety. CUMS-mice orally administered with Psycodigest (0.23ml /mice), Fluoxetine (20mg/kg), and Bupropion (15mg/kg) for 4 weeks. The antidepressant effects were evaluated by sucrose preference, tail suspension, and forced swimming test. The anxiolytic effect was tested by elevated plus maze. Besides, the brain, kidney, liver super oxidase dismutase (SOD) activity, and plasma level of cortisol, creatinine and alanine aminotransferase (ALT) were detected. The histopathological effects evaluated on kidney, liver, intestine and brain. The daily oral administration of Psycodigest as well as Fluoxetine and Bupropion had antidepressant, but no anxiolytic effect. Psycodigest did not change the serum level of cortisol, ALT and creatinine. Also hematological and histological examinations were not affected. Meanwhile, the brain SOD activity increased followed by Psycodigest treatment, the kidney and liver SOD did not change. The chronic administration of Psycodigest significantly ameliorated the depressive-like behaviors and showed the antioxidative effect in the brain with no toxicity in the liver and kidney.